Barnett Eva Renee
Immunovant, Inc. · Chief Financial Officer
Barnett Eva Renee is listed in filings as Chief Financial Officer at Immunovant, Inc.. This profile follows SEC Form 4 activity through Apr 17, 2025, including sale activity. Recent filings connect the profile to Immunovant, Inc. (IMVT). The current snapshot covers public activity from Jul 10, 2024 to Apr 17, 2025. Reported amounts are shown as $44.6K to $58.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $59k2.8k shares | SellFeb 19, 2025 | $20.86 | $38.96 | |
| $2.6k109 shares | SellJan 15, 2025 | $24.19 | $38.96 | |
| $52k2.2k shares | SellJan 15, 2025 | $23.81 | $38.96 | |
| $99k4.1k shares | SellJan 8, 2025 | $24.10 | $38.96 | |
| $106k4.2k shares | SellNov 20, 2024 | $25.45 | $38.96 | |
| $94k3.3k shares | SellOct 16, 2024 | $28.79 | $38.96 | |
| $153k5.2k shares | SellOct 9, 2024 | $29.56 | $38.96 | |
| $4.8k149 shares | SellAug 21, 2024 | $32.32 | $38.96 | |
| $115k3.6k shares | SellAug 21, 2024 | $31.84 | $38.96 | |
| $87k2.9k shares | SellJul 17, 2024 | $29.64 | $38.96 | |
| $5.6k184 shares | SellJul 17, 2024 | $30.55 | $38.96 | |
| $133k4.7k shares | SellJul 9, 2024 | $28.06 | $38.96 |